首页> 美国卫生研究院文献>Journal of Translational Medicine >Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014 Center for Applied Medical Research and University Clinic Pamplona Spain
【2h】

Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014 Center for Applied Medical Research and University Clinic Pamplona Spain

机译:将癌症免疫学和免疫疗法从实验室转移到诊所2014年3月4日至5日西班牙潘普洛纳应用医学研究中心和大学诊所

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

New approaches to generate effective anticancer responses by either inducing immune responses or inhibiting immunosuppression are under development to improve efficacy in patients. On March 4-5th, 2014, a symposium was held in Pamplona, Spain, to report the new strategies showing preclinical and clinical results regarding translational research efforts on the topic. Participants interacted through oral presentations of 15 speakers and further discussions on topics that included novel therapeutic agents for cancer immunotherapy, viral vectors and interferon-based approaches, experimental tumor imaging and immunostimulatory monoclonal antibodies. Promising agents to target cancer cells and therapeutic approaches that are under translation from bench to patients were presented.
机译:通过诱导免疫反应或抑制免疫抑制产生有效抗癌反应的新方法正在开发中,以提高患者的疗效。 2014年3月4日至5日,在西班牙潘普洛纳举行了座谈会,报告了有关该主题转化研究成果的临床前和临床结果的新策略。与会者通过15位发言人的口头报告进行了互动,并就以下主题进行了进一步讨论:主题包括用于癌症免疫疗法的新型治疗剂,病毒载体和基于干扰素的方法,实验性肿瘤成像和免疫刺激性单克隆抗体。介绍了靶向癌细胞的有希望的药物和正在从实验台到患者的翻译中的治疗方法。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号